BiotechTube
Home/PureTech Health/Michael Inbar, CPA, MBA
MI

Michael Inbar, CPA, MBA

Chief Accounting Officer

PureTech Health

Therapeutic Areas

ImmunologyNeurologyGastroenterologyPsychiatryOncologyMetabolic Disease

PureTech Health Pipeline

DrugIndicationPhase
GlyphAllo™ (SPT-300)Neuropsychiatric disordersPhase 1b/2a
Plenity®Weight managementApproved
LYT-100 (deupirfenidone)Fibrotic diseases (e.g., IPF)Phase 2
LYT-200Oncology (solid tumors)Phase 1/2
LYT-300Anxiety disordersPhase 1
LYT-310EpilepsyPreclinical
EndeavorRx®Pediatric ADHDApproved
KarXT (Cobenfy™)SchizophreniaApproved

Leadership Team at PureTech Health

RL
Robert Lyne
Chief Executive Officer
EE
Eric Elenko, PhD
Co-founder & President
SB
Sharon Barber-Lui
Interim Chair of the Board of Directors
MH
Michele Holcomb, PhD
Non-Executive Director
View full PureTech Health profile